microlax

Medicinal product

(Invented) name

microlax

Active substance (s)

Sorbitolis/Natrio citratas/Natrio laurilsulfoacetatas

Strength

625 mg/90 mg/9 mg/ml

Pharmaceutical form

tiesiosios žarnos tirpalas

Route (s) of administration

vartoti į tiesiąją žarną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

ATC code (s)

A06AG11, sodium lauryl sulfoacetate, incl. combinations

Marketing authorisation holder

McNeil AB, Švedija

Date of authorisation

1997-09-03

Date of renewal

2011-06-15

Documents

Stage

Perregistruotas

Controlled?

Controlled substance type

Legal basis

10a

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

1 ml tirpalo yra	1 ml
Sorbitolis	625 mg
Natrio citratas dihidratas	90 mg
Natrio laurilsulfoacetatas	9 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
11870	16297	1016297	tūbelė	5 ml N4		Nereceptinis	LT/1/97/0013/001	Tiekiama	-	-	No	-	-	Download
11871	16298	1016298	tūbelė	5 ml N12		Nereceptinis	LT/1/97/0013/002	Tiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2011-06-15	Perregistruotas
1997-09-03	Registruotas